Barrow, Hanley, Mewhinney & Strauss’s Trueblue TBI Stock Holding History
Bought
Maintained
Sold
Other funds holding TBI
Barrow, Hanley, Mewhinney & Strauss's TBI Position: Q2 2022 in Review
Barrow, Hanley, Mewhinney & Strauss sold out of Trueblue (TBI) in Q2 2022, closing a stake of 432 shares — an estimated $12K sold.
Barrow, Hanley, Mewhinney & Strauss first reported a position in TBI in Q1 2015 and held it in 22 quarters. The position peaked at $4.81M in Q2 2018. 173 funds tracked by Wall St. Rank hold TBI as of Q2 2022.
- Barrow, Hanley, Mewhinney & Strauss reported no remaining Trueblue position as of Q2 2022 after selling out during the quarter.
- Barrow, Hanley, Mewhinney & Strauss sold 432 Trueblue shares in Q2 2022, an estimated $12K.
- Barrow, Hanley, Mewhinney & Strauss first reported a position in Trueblue in Q1 2015 and held it in 22 quarters.
- Barrow, Hanley, Mewhinney & Strauss's Trueblue position peaked at $4.81M in Q2 2018.
- 173 funds tracked by Wall St. Rank held Trueblue as of Q2 2022.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2022, filed 11 Aug 2022.